Cargando…

Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors

Cisplatin-based concurrent chemoradiotherapy (CCRT) is a standard treatment for cervical cancer, but nedaplatin-based CCRT is not routinely administered. We evaluated the efficacy and safety of nedaplatin-based CCRT (35 mg/m(2) weekly) and analyzed prognostic factors for survival among 52 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujiwara, Masateru, Isohashi, Fumiaki, Mabuchi, Seiji, Yoshioka, Yasuo, Seo, Yuji, Suzuki, Osamu, Sumida, Iori, Hayashi, Kazuhiko, Kimura, Tadashi, Ogawa, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380049/ https://www.ncbi.nlm.nih.gov/pubmed/25428244 http://dx.doi.org/10.1093/jrr/rru101

Ejemplares similares

Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
por: Mabuchi, Seiji, et al.
Publicado: (2017)

Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters
por: Isohashi, Fumiaki, et al.
Publicado: (2015)

Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method
por: Hayashi, Kazuhiko, et al.
Publicado: (2015)

Dose–volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy
por: Isohashi, Fumiaki, et al.
Publicado: (2016)

Treatment outcomes using CyberKnife for brain metastases from lung cancer
por: Tamari, Keisuke, et al.
Publicado: (2015)

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial
por: He, Shasha, et al.
Publicado: (2022)

Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2011)

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

Correlation between patients’ anatomical characteristics and interfractional internal prostate motion during intensity modulated radiation therapy for prostate cancer
por: Maruoka, Shintaroh, et al.
Publicado: (2015)

The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix
por: Takahashi, Yutaka, et al.
Publicado: (2012)

A 3-year follow-up study of radiotherapy using computed tomography–based image-guided brachytherapy for cervical cancer
por: Kawashima, Atsushi, et al.
Publicado: (2019)

Organ-specific modulation complexity score for the evaluation of dose delivery
por: Sumida, Iori, et al.
Publicado: (2017)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
por: Wu, Qiuji, et al.
Publicado: (2021)

Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
por: Huo, Rui-Xue, et al.
Publicado: (2022)

Three-dimensional dose prediction and validation with the radiobiological gamma index based on a relative seriality model for head-and-neck IMRT
por: Hamatani, Noriaki, et al.
Publicado: (2017)

Dosimetric comparison between volumetric modulated arc therapy planning techniques for prostate cancer in the presence of intrafractional organ deformation
por: Varnava, Maria, et al.
Publicado: (2020)

Gemstone spectral imaging: determination of CT to ED conversion curves for radiotherapy treatment planning
por: Yagi, Masashi, et al.
Publicado: (2013)

Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin
por: Liang, Xuexia, et al.
Publicado: (2022)

A phase III randomized, controlled trial of nedaplatin versus cisplatin concurrent chemoradiotherapy in patients with cervical cancer
por: Yang, X., et al.
Publicado: (2022)

Evaluation of the radiobiological gamma index with motion interplay in tangential IMRT breast treatment
por: Sumida, Iori, et al.
Publicado: (2016)

Robust plan optimization using edge-enhanced intensity for intrafraction organ deformation in prostate intensity-modulated radiation therapy
por: Sumida, Iori, et al.
Publicado: (2017)

Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate
por: Kanayama, Naoyuki, et al.
Publicado: (2015)

Comparison of gamma index based on dosimetric error and clinically relevant dose–volume index based on three-dimensional dose prediction in breast intensity-modulated radiation therapy
por: Kaneko, Akari, et al.
Publicado: (2019)

Curtailing patient-specific IMRT QA procedures from 2D dose error distribution
por: Kurosu, Keita, et al.
Publicado: (2016)

Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer
por: Kong, Tae Wook, et al.
Publicado: (2012)

Preventing Complications from High-Dose Rate Brachytherapy when Treating Mobile Tongue Cancer via the Application of a Modular Lead-Lined Spacer
por: Murakami, Shumei, et al.
Publicado: (2016)

Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery
por: Laurentius, Thea, et al.
Publicado: (2010)

Characterization of a microSilicon diode detector for small-field photon beam dosimetry
por: Akino, Yuichi, et al.
Publicado: (2020)

Feasibility of synthetic computed tomography generated with an adversarial network for multi-sequence magnetic resonance-based brain radiotherapy
por: Koike, Yuhei, et al.
Publicado: (2019)

Impact of different Ir-192 source models on dose calculations in high-dose-rate brachytherapy
por: Otani, Yuki, et al.
Publicado: (2018)

Three‐dimensional dose prediction based on two‐dimensional verification measurements for IMRT
por: Sumida, Iori, et al.
Publicado: (2014)

A new plan quality objective function for determining optimal collimator combinations in prostate cancer treatment with stereotactic body radiation therapy using CyberKnife
por: Varnava, Maria, et al.
Publicado: (2018)

Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System
por: Meng, Qingyu, et al.
Publicado: (2022)

Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer
por: Zhang, Yue, et al.
Publicado: (2023)

Feasibility of virtual starshot analysis providing submillimeter radiation isocenter accuracy: A long‐term multi‐institutional analysis
por: Akino, Yuichi, et al.
Publicado: (2019)

Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
por: Sumida, Iori, et al.
Publicado: (2016)

Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy
por: Zeng, Jing, et al.
Publicado: (2022)

Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study
por: Zhang, Hao, et al.
Publicado: (2022)

The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas
por: Brambs, Christine E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2tkueu5lbjj6huqgsr8i92suap